ArticleJournal of experimental & clinical cancer research : CR2023

AR antagonists develop drug resistance through TOMM20 autophagic degradation-promoted transformation to neuroendocrine prostate cancer.

Linglong Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.